Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women

Inclusion Criteria: * Female outpatients 18 years or older. * Overactive bladder symptoms (subject-reported) for greater than or equal to 3 months. * Currently sexually active with a male partner. Exclusion Criteria: * Diagnosed or suspected interstitial cystitis, uninvestigated hematuria, urogenital cancer, and interstitial or external radiation to the pelvis or external genitalia or clinically significant bladder outlet obstruction. * Symptoms of incontinence being predominately stress urinary incontinence as determined by the investigator. * Treated with antimuscarinic/ anticholinergic medication, for any reason including OAB, within the last 3 months or are expected to start therapy during the study treatment period. * Any drug for urgency urinary incontinence (UUI) initiated within the past 3 months prior to Visit 1, with the exception of estrogen (topical or systemic) as long as treatment is not initiated within 4 weeks prior to Visit 1 (screening)